🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single arm study to study the safety, efficacy and t...
Status
Completed
Location
Valkyrie Clinical Trials
Start Date
2022-04-29
Trial ID
NCT05253807
Treatments Being Tested
Primary objective: ● To evaluate the efficacy of pemigatinib in advanced n...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2021-12-06
Trial ID
NCT05210946
Treatments Being Tested
This study is a prospective single-arm phase II clinical study. Advanced no...
Status
Unknown
Location
the First Affiliated Hospital of Xiamen University
Start Date
2022-01-21
Trial ID
NCT05287386
Treatments Being Tested
This is a prospective non-randomized national clinical phase 2 trial that a...
Status
Recruiting
Location
Turku University Hospital Cancer Centre
Start Date
2021-12-10
Trial ID
NCT05159245
This is a single arm phase II study of pemigatinib and durvalumab combinati...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-01-27
Trial ID
NCT06728410
Treatments Being Tested
This study was conducted as a second-line treatment of recurrent / progress...
Status
Completed
Location
Yonsei University Health System, Severance Hospital
Start Date
2019-05-27
Trial ID
NCT05529667
Treatments Being Tested
This phase II trial tests how well giving gemcitabine, cisplatin and durval...
Status
Not Yet Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-11-01
Trial ID
NCT07780838
The purpose of this clinical trial is to demonstrate the benefit of Pemigat...
Status
Terminated
Location
ASST Papa Giovanni XXIII
Start Date
2020-07-13
Trial ID
NCT04294277
Treatments Being Tested
This is a Prospective, single-arm, phase II study with multicenter particip...
Status
Unknown
Location
Lei Zhang
Start Date
2023-07
Trial ID
NCT05913661
Treatments Being Tested
This study is a prospective single-arm phase II clinical study. HER2-negati...
Status
Unknown
Location
Breast Oncology, Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-09-08
Trial ID
NCT05560334
Treatments Being Tested